Eli Lilly (LLY) is reportedly preparing to launch Mounjaro in Denmark, the home country of its leading rival in the ...

Danish pharmaceutical company Novo Nordisk (NYSE: NVO) is pioneering a new wave of medical treatment for diabetes and obesity ...

Nearly one in four adults in Louisiana are considered obese, so it may not come as a surprise that our state also leads the ...

The insulin is facing supply shortages as diabetes patients increasingly turn to GLP-1 weight loss drugs such as Ozempic and ...

Lilly will launch its Mounjaro obesity drug in Denmark next week, the U.S. drugmaker said on Thursday, bringing competition ...

Losing weight in menopause can help with the severity of other menopause symptoms like hot flashes and night sweats, ...

A staggering 64% of adults in England are classed as either overweight or obese according to the most recent NHS figures. And ...

Advocates for diabetes patients who need insulin to survive worry the nation's supply is unreliable. Meanwhile, use of ...

Some patients fear tirzepatide, sold by Eli Lilly under the brand names Zepbound and Mounjaro, will be hard to get and prohibitively expensive once compounding pharmacies are no longer producing it.

FDA recalls thousands of antidepressant bottles due to cancer-causing chemical{beacon} Health Care Health Care   The Big ...

A new report found people selling leftover weight loss drugs, like Ozempic or Mounjaro, on Facebook. Doctors are ...

A new study suggests weight loss drugs like Ozempic and Mounjaro could provide a promising new treatment for substance use ...